Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 5
- +1 vs. Q4 2021
- Portfolio value
- $185.5M
- −$100.2M (−35.1%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $63.0M | 33.9% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $52.9M | 28.5% | 00.0% | Unchanged | History |
| ISOIsoPlexis Corp | COM | 8,808,531 | $30.2M | 16.3% | +3,2590.0% | Added | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $29.6M | 16.0% | +4,214,498 | New | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $9.85M | 5.3% | 00.0% | Unchanged | History |